Pharmaceuticals

Viral Vector Production (Research-Use) Market Outlook 2026–2030 driven by gene therapy demand

March 25, 2026March 25, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Viral Vector Production (Research-Use) Market In 2026 And What Value Is Projected For 2030?

The market size for viral vector production (research-use) has seen rapid expansion in recent years. Projections indicate it will expand from $1.77 billion in 2025 to reach $2.04 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 15.2%. Historically, this growth can be attributed to several factors, including increased investment in gene therapy research, the broadening of academic and translational research programs, the availability of cutting-edge cell culture technologies, the escalating application of viral vectors in oncology studies, and the expansion of contract research activities.

The market size for viral vector production (research-use) is anticipated to experience swift expansion over the next few years. It is projected to reach $3.56 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. This growth during the forecast period is attributable to factors such as increasing demand for next-generation gene delivery tools, rising adoption of automation within research laboratories, the expansion of CRISPR and gene editing research, growing collaboration between academia and biopharma, and an increasing focus on reproducibility and standardization. Prominent trends expected in the forecast period include the increasing adoption of scalable viral vector manufacturing platforms, a rising demand for high-purity research-grade vectors, the growing use of suspension cell culture systems, an expansion of automated upstream and downstream processing, and an enhanced focus on vector characterization and quality control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Viral Vector Production (Research-Use) Market?

The increased occurrence of genetic disorders is anticipated to stimulate the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are conditions or illnesses resulting from irregularities in an individual’s deoxyribonucleic acid, which can be inherited from one or both parents or emerge from new genetic mutations. The uptick in genetic disorders is linked to rising parental age, thereby increasing the probability of genetic mutations being passed to offspring. The expanding incidence of genetic disorders supports the development of viral vector production (research-use) by fueling the need for advanced gene delivery tools to investigate disease mechanisms and formulate potential therapeutic strategies. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Thus, the growing occurrence of genetic disorders is projected to drive the growth of the viral vector production (research-use) market.

What Are The Key Segments Of The Viral Vector Production (Research-Use) Market?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

What Key Trends Are Influencing The Development Of The Viral Vector Production (Research-Use) Market?

Firms operating in the viral vector production market are concentrating on developing sophisticated solutions, such as specialized cell culture media, to enhance transfection efficiency, boost viral vector yields, and maintain uniform quality for research purposes. These cell culture media are nutrient-dense preparations intended to sustain cell growth and upkeep outside their natural habitat. They comprise vital elements such as amino acids, vitamins, and growth factors, tailored for particular cell types and uses. As an illustration, FUJIFILM Irvine Scientific, a US-based life sciences firm, launched BalanCD HEK293 Viral Feed in January 2023. This product represents the world’s initial chemically defined nutrient feed, specifically optimized for HEK293 suspension cultures employed in AAV viral vector manufacturing. With this introduction, the company intends to substantially increase adeno-associated virus (AAV) yields, showing up to 67% greater viral packaging efficiency than with basal media. This feed is engineered for scalable gene therapy and biotechnology workflows, providing uniform performance across various formats and compatibility with numerous media systems.

Who Are The Leading Companies Operating In The Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Read the full viral vector production (research-use) market report here:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

What Are The Leading Geographic Regions In The Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Viral Vector Production (Research-Use) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28350&type=smp

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795